March 2022

Kither Biotech announces publication of new data in Science Translational Medicine

Kither Biotech announces publication of new data in Science Translational Medicine Data support the use of Kither Biotech’s lead asset, KIT2014, in obstructive airway diseases KIT2014 demonstrated a triple mechanism of action in reversing disease pathogenesis: enhancing functionality of CFTR channels and reducing bronchoconstriction and inflammation Adds to evidence supporting

Read More

GCP Announces Asia Pacific Price Increase on all construction products

SINGAPORE, March 30, 2022 (GLOBE NEWSWIRE) — GCP Applied Technologies Inc. (NYSE: GCP) (GCP or the Company), a leading global provider of construction products, today announced it is implementing price increases for Concrete Admixtures, Cement Additives and Specialty Building Materials in Asia Pacific. To continue providing the exceptional solutions GCP’s

Read More